Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Sunitinib Prior to Planned Nephrectomy in Metastatic Renal Cell Carcinoma: Angiogenesis Biomarkers Predict Clinical Outcome in the Prospective Phase II PREINSUT Trial.

Mauge L, Mejean A, Fournier L, Pereira H, Etienne-Grimaldi MC, Levionnois E, Caty A, Abadie-Lacourtoisie S, Culine S, Le Moulec S, Linassier C, Théodore C, Ravaud A, Albiges L, Grine A, Tartour E, Milano G, Gille AS, Verkarre V, Helley D, Oudard S; PREINSUT study group.

Clin Cancer Res. 2018 Jul 30. doi: 10.1158/1078-0432.CCR-18-1045. [Epub ahead of print]

PMID:
30061359
2.

Beta-1,4-galactosyltransferase 2 c.909C>T gene variant is predictive of on-clopidogrel platelet reactivity.

Pallet N, Belleville-Rolland T, Savalle A, Lejeune M, Mauge L, Bertil S, Loriot MA, Gaussem P.

Pharmacogenomics. 2018 Aug 1;19(12):937-945. doi: 10.2217/pgs-2018-0057. Epub 2018 Jul 18.

PMID:
30020015
3.

Acquired hemophilia A resolution in a hepatitis C virus/human immunodeficiency virus-coinfected patient with cure of hepatitis C by direct-acting antiviral agents.

Mauge L, Pavie J, Batisse D, Darnige L.

Hepatology. 2017 Sep 28. doi: 10.1002/hep.29560. [Epub ahead of print] No abstract available.

PMID:
28960371
4.

[State of the art: Direct oral anticoagulants and transfusion].

Martin AC, Godier A, Smadja DM, Mauge L, Fischer AM.

Transfus Clin Biol. 2017 Sep;24(3):154-159. doi: 10.1016/j.tracli.2017.05.019. Epub 2017 Jun 30. Review. French.

PMID:
28673500
5.

Sunitinib in kidney cancer: 10 years of experience and development.

Nassif E, Thibault C, Vano Y, Fournier L, Mauge L, Verkarre V, Timsit MO, Mejean A, Tartour E, Oudard S.

Expert Rev Anticancer Ther. 2017 Feb;17(2):129-142. doi: 10.1080/14737140.2017.1272415. Epub 2016 Dec 27. Review.

PMID:
27967249
6.

Synergy of Radiotherapy and a Cancer Vaccine for the Treatment of HPV-Associated Head and Neck Cancer.

Mondini M, Nizard M, Tran T, Mauge L, Loi M, Clémenson C, Dugue D, Maroun P, Louvet E, Adam J, Badoual C, Helley D, Dransart E, Johannes L, Vozenin MC, Perfettini JL, Tartour E, Deutsch E.

Mol Cancer Ther. 2015 Jun;14(6):1336-45. doi: 10.1158/1535-7163.MCT-14-1015. Epub 2015 Apr 1.

7.

Activated partial thromboplastin time sensitivity to lupus anticoagulant in a patient with transient arthritis and lupus anticoagulant-hypoprothrombinemia syndrome.

Mauge L, Passeron A, Alhenc-Gelas M, Pouchot J, Darnige L.

Ann Hematol. 2015 Apr;94(4):713-5. doi: 10.1007/s00277-014-2245-3. Epub 2014 Nov 9. No abstract available.

PMID:
25380995
8.

Tie2-dependent deletion of α6 integrin subunit in mice reduces tumor growth and angiogenesis.

Bouvard C, Segaoula Z, De Arcangelis A, Galy-Fauroux I, Mauge L, Fischer AM, Georges-Labouesse E, Helley D.

Int J Oncol. 2014 Nov;45(5):2058-64. doi: 10.3892/ijo.2014.2631. Epub 2014 Sep 1.

PMID:
25176420
9.

[Stability of coagulation parameters: review of available data].

Mauge L, Alhenc-Gelas M.

Ann Biol Clin (Paris). 2014 Mar-Apr;72(2):141-5. doi: 10.1684/abc.2014.0939. Review. French.

10.

Control of the adaptive immune response by tumor vasculature.

Mauge L, Terme M, Tartour E, Helley D.

Front Oncol. 2014 Mar 28;4:61. doi: 10.3389/fonc.2014.00061. eCollection 2014. Review.

11.

In vitro inflammatory/anti-inflammatory effects of nitrate esters of purines.

Maugé L, Fotopoulou T, Delemasure S, Dutartre P, Koufaki M, Connat JL.

Eur J Pharmacol. 2014 May 5;730:148-56. doi: 10.1016/j.ejphar.2014.02.022. Epub 2014 Mar 5.

PMID:
24613657
12.

Forearm ischemia decreases endothelial colony-forming cell angiogenic potential.

Mauge L, Sabatier F, Boutouyrie P, D'Audigier C, Peyrard S, Bozec E, Blanchard A, Azizi M, Dizier B, Dignat-George F, Gaussem P, Smadja DM.

Cytotherapy. 2014 Feb;16(2):213-24. doi: 10.1016/j.jcyt.2013.09.007. Epub 2013 Nov 23.

PMID:
24280239
13.

HIF-prolyl hydroxylase 2 inhibition enhances the efficiency of mesenchymal stem cell-based therapies for the treatment of critical limb ischemia.

HoWangYin KY, Loinard C, Bakker W, Guérin CL, Vilar J, d'Audigier C, Mauge L, Bruneval P, Emmerich J, Lévy BI, Pouysségur J, Smadja DM, Silvestre JS.

Stem Cells. 2014 Jan;32(1):231-43. doi: 10.1002/stem.1540. Erratum in: Stem Cells. 2014 Apr;32(4):1055-7. D'Audigier, Clément [corrected to d'Audigier, Clément].

14.

Circulating endothelial cells in refractory pulmonary hypertension in children: markers of treatment efficacy and clinical worsening.

Levy M, Bonnet D, Mauge L, Celermajer DS, Gaussem P, Smadja DM.

PLoS One. 2013 Jun 10;8(6):e65114. doi: 10.1371/journal.pone.0065114. Print 2013. Erratum in: PLoS One. 2014;9(1). doi:10.1371/annotation/ad9cc7fc-af50-4658-bd90-e3aaf0def017.

15.

Imbalance of circulating endothelial cells and progenitors in idiopathic pulmonary fibrosis.

Smadja DM, Mauge L, Nunes H, d'Audigier C, Juvin K, Borie R, Carton Z, Bertil S, Blanchard A, Crestani B, Valeyre D, Gaussem P, Israel-Biet D.

Angiogenesis. 2013 Jan;16(1):147-57. doi: 10.1007/s10456-012-9306-9. Epub 2012 Sep 16.

PMID:
22983452
16.

A specific time course for mobilization of peripheral blood CD34+ cells after plerixafor injection in very poor mobilizer patients: impact on the timing of the apheresis procedure.

Lefrère F, Mauge L, Réa D, Ribeil JA, Dal Cortivo L, Brignier AC, Aoun C, Larghéro J, Cavazzana-Calvo M, Micléa JM.

Transfusion. 2013 Mar;53(3):564-9. doi: 10.1111/j.1537-2995.2012.03744.x. Epub 2012 Jun 21.

PMID:
22725259
17.

The profibrotic cytokine transforming growth factor-β1 increases endothelial progenitor cell angiogenic properties.

Evrard SM, d'Audigier C, Mauge L, Israël-Biet D, Guerin CL, Bieche I, Kovacic JC, Fischer AM, Gaussem P, Smadja DM.

J Thromb Haemost. 2012 Apr;10(4):670-9. doi: 10.1111/j.1538-7836.2012.04644.x.

18.

Angiogenic potential of BM MSCs derived from patients with critical leg ischemia.

Smadja DM, d'Audigier C, Guerin CL, Mauge L, Dizier B, Silvestre JS, Dal Cortivo L, Gaussem P, Emmerich J.

Bone Marrow Transplant. 2012 Jul;47(7):997-1000. doi: 10.1038/bmt.2011.196. Epub 2011 Oct 10. No abstract available.

PMID:
21986637
19.

Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties.

Smadja DM, d'Audigier C, Bièche I, Evrard S, Mauge L, Dias JV, Labreuche J, Laurendeau I, Marsac B, Dizier B, Wagner-Ballon O, Boisson-Vidal C, Morandi V, Duong-Van-Huyen JP, Bruneval P, Dignat-George F, Emmerich J, Gaussem P.

Arterioscler Thromb Vasc Biol. 2011 Mar;31(3):551-9. doi: 10.1161/ATVBAHA.110.220624. Epub 2010 Dec 9.

PMID:
21148423
20.

Treprostinil increases the number and angiogenic potential of endothelial progenitor cells in children with pulmonary hypertension.

Smadja DM, Mauge L, Gaussem P, d'Audigier C, Israel-Biet D, Celermajer DS, Bonnet D, Lévy M.

Angiogenesis. 2011 Mar;14(1):17-27. doi: 10.1007/s10456-010-9192-y. Epub 2010 Nov 4.

21.

The Wnt antagonist Dickkopf-1 increases endothelial progenitor cell angiogenic potential.

Smadja DM, d'Audigier C, Weiswald LB, Badoual C, Dangles-Marie V, Mauge L, Evrard S, Laurendeau I, Lallemand F, Germain S, Grelac F, Dizier B, Vidaud M, Bièche I, Gaussem P.

Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2544-52. doi: 10.1161/ATVBAHA.110.213751. Epub 2010 Sep 16.

PMID:
20847303
22.

Distinct patterns of circulating endothelial cells in pulmonary hypertension.

Smadja DM, Mauge L, Sanchez O, Silvestre JS, Guerin C, Godier A, Henno P, Gaussem P, Israël-Biet D.

Eur Respir J. 2010 Dec;36(6):1284-93. doi: 10.1183/09031936.00130809. Epub 2010 Apr 22.

23.

Comparison of endothelial biomarkers according to reversibility of pulmonary hypertension secondary to congenital heart disease.

Smadja DM, Gaussem P, Mauge L, Lacroix R, Gandrille S, Remones V, Peyrard S, Sabatier F, Bonnet D, Lévy M.

Pediatr Cardiol. 2010 Jul;31(5):657-62. doi: 10.1007/s00246-010-9674-0. Epub 2010 Feb 27.

PMID:
20195855
24.

Circulating endothelial cells: a new candidate biomarker of irreversible pulmonary hypertension secondary to congenital heart disease.

Smadja DM, Gaussem P, Mauge L, Israël-Biet D, Dignat-George F, Peyrard S, Agnoletti G, Vouhé PR, Bonnet D, Lévy M.

Circulation. 2009 Jan 27;119(3):374-81. doi: 10.1161/CIRCULATIONAHA.108.808246. Epub 2009 Jan 12.

PMID:
19139384
25.

Blood outgrowth endothelial cells from cord blood and peripheral blood: angiogenesis-related characteristics in vitro: a rebuttal.

Smadja DM, Mauge L, Susen S, Bieche I, Gaussem P.

J Thromb Haemost. 2009 Mar;7(3):504-6; author reply 506-8. doi: 10.1111/j.1538-7836.2008.03247.x. No abstract available.

26.

Interleukin 8 is differently expressed and modulated by PAR-1 activation in early and late endothelial progenitor cells.

Smadja DM, Bièche I, Susen S, Mauge L, Laurendeau I, d'Audigier C, Grelac F, Emmerich J, Aiach M, Gaussem P.

J Cell Mol Med. 2009 Aug;13(8B):2534-46. doi: 10.1111/j.1582-4934.2008.00429.x. Epub 2008 Jul 23.

Supplemental Content

Support Center